Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in low/middle-income countries: An analysis of Indonesia.
<h4>Background</h4>Recent evidence suggests that 1 dose of the human papillomavirus (HPV) vaccine may have similar effectiveness in reducing HPV infection risk compared to 2 or 3 doses.<h4>Objective</h4>To evaluate the public health impact and cost-effectiveness of implementi...
Saved in:
| Main Authors: | Vincent Daniels, Kunal Saxena, Oscar Patterson-Lomba, Andres Gomez-Lievano, Jarir At Thobari, Nancy Durand, Evan Myers |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0310591 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of Human Papillomavirus 9-Valent Vaccine: A Meta-Analysis of Randomized Trials
by: Ana Paula Ferreira Costa, et al.
Published: (2017-01-01) -
Stability study of recombinant 9-valent human papillomavirus vaccine based on Escherichia coli expression system
by: Yuying Liu, et al.
Published: (2025-12-01) -
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
by: Kwame Owusu-Edusei, et al.
Published: (2022-06-01) -
Adverse events following 9-valent human papillomavirus vaccine (GARDASIL® 9) reported to the Vaccine Adverse Event Reporting System (VAERS), 2015–2024
by: Qiong Liu, et al.
Published: (2025-12-01) -
Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis
by: Jing Wu, et al.
Published: (2019-11-01)